Circulating lipid levels and risk of coronary artery disease in a large group of patients undergoing coronary angiography

Journal of Thrombosis and Thrombolysis

Volumn 39, Issue 1, 2015, Pages 15-22

  Platt, Daniel E ^a   Ghassibe Sabbagh, Michella ^b   Youhanna, Sonia ^b   Hager, Jörg ^c   Cazier, Jean Baptiste ^d   Kamatani, Yoichiro ^e   Salloum, Angelique K ^b   Haber, Marc ^b   Romanos, Jihane ^b   Doueihy, Bouchra ^b   Mouzaya, Francis ^b   Kibbani, Samer ^f   Sbeite, Hana ^b   Deeb, Mary E ^b   Chammas, Elie ^b   el Bayeh, Hamid ^b   Khazen, Georges ^b   Gauguier, Dominique ^d,g   Zalloua, Pierre A ^b,h   Abchee, Antoine B ⁱ  

^a IBM T J WATSON RESEARCH CENTER   (United States)

^b LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^c CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^g CENTRE DE RECHERCHE DES CORDELIERS   (France)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Atherosclerosis; Coronary artery disease; HDL; Heart lipid metabolism; Lipid analysis; Plasma lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANGIOCARDIOGRAPHY; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RADIOGRAPHY;

AGED; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84939893738     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1069-2     Document Type: Article

References (28)

1. Gaziano TA (2005) Cardiovascular disease in the developing world and its cost-effective management. Circulation 112:3547–3553
2. Gaziano TA (2007) Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood) 26:13–24
3. Jomini V, Oppliger-Pasquali S, Wietlisbach V, Rodondi N, Jotterand V, Paccaud F, Darioli R, Nicod P, Mooser V (2002) Contribution of major cardiovascular risk factors to familial premature coronary artery disease: the GENECARD project. J Am Coll Cardiol 40:676–684
4. Wilson PW (2008) CETP genes, metabolic effects, and coronary disease risk. JAMA 299:2795–2796
5. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:937–952
6. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW (2003) Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290:891–897
7. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497
8. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ et al (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000
9. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370:1829–1839
10. Neaton JD, Wentworth D (1992) Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 152:56–64
11. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH et al (1986) The diet and 15-year death rate in the seven countries study. Am J Epidemiol 124:903–915
12. Castelli WP (1984) Epidemiology of coronary heart disease: the Framingham study. Am J Med 76:4–12
13. Levy D, Kannel WB (1988) Cardiovascular risks: new insights from Framingham. Am Heart J 116:266–272
14. Kannel WB (2005) Risk stratification of dyslipidemia: insights from the Framingham study. Curr Med Chem Cardiovasc Hematol Agents 3:187–193
15. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57
16. Grover SA, Palmer CS, Coupal L (1994) Serum lipid screening to identify high-risk individuals for coronary death. The results of the lipid research clinics prevalence cohort. Arch Intern Med 154:679–684
17. Kannel WB, Wilson PW (1992) Efficacy of lipid profiles in prediction of coronary disease. Am Heart J 124:768–774
18. Nair D, Carrigan TP, Curtin RJ, Popovic ZB, Kuzmiak S, Schoenhagen P, Flamm SD, Desai MY (2009) Association of total cholesterol/high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography. Prev Cardiol 12:19–26
19. Penalva RA, Huoya Mde O, Correia LC, Feitosa GS, Ladeia AM (2008) Lipid profile and intensity of atherosclerosis disease in acute coronary syndrome. Arq Bras Cardiol 90:24–30
20. Wang F, Xu CQ, He Q, Cai JP, Li XC, Wang D, Xiong X, Liao YH, Zeng QT, Yang YZ et al (2011) Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 43:345–349
21. Team RDC (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. ISBN 3-900051-07-0
22. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN et al (2002) ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106:1893–1900
23. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562–1569
24. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL et al (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127–135
25. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ et al (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198–1205
26. Ma XY, Liu JP, Song ZY (2011) Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Atherosclerosis 215:428–434
27. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Holm H, Ding EL, Johnson T et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380:572–580
28. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM (2009) Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119:931–939